OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 131 filers reported holding OCULAR THERAPEUTIX INC in Q1 2022. The put-call ratio across all filers is 1.09 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $364,554 | -48.2% | 116,100 | -14.8% | 0.00% | -50.0% |
| Q2 2023 | $703,308 | -58.7% | 136,300 | -57.9% | 0.00% | -60.0% |
| Q1 2023 | $1,704,444 | +220.8% | 323,424 | +71.0% | 0.01% | +150.0% |
| Q4 2022 | $531,329 | -35.3% | 189,085 | -4.4% | 0.00% | -33.3% |
| Q3 2022 | $821,000 | -65.7% | 197,760 | -59.1% | 0.00% | -57.1% |
| Q1 2022 | $2,392,000 | -27.0% | 483,284 | +2.9% | 0.01% | 0.0% |
| Q4 2021 | $3,275,000 | -63.4% | 469,866 | -47.5% | 0.01% | -65.0% |
| Q3 2021 | $8,954,000 | -39.1% | 895,400 | -13.6% | 0.02% | -39.4% |
| Q2 2021 | $14,691,000 | -23.4% | 1,036,045 | -11.3% | 0.03% | -34.0% |
| Q1 2021 | $19,174,000 | +0.7% | 1,168,458 | +27.0% | 0.05% | -9.1% |
| Q4 2020 | $19,050,000 | +657.8% | 920,295 | +178.6% | 0.06% | +511.1% |
| Q3 2020 | $2,514,000 | +59.7% | 330,300 | +74.8% | 0.01% | +12.5% |
| Q2 2020 | $1,574,000 | +1200.8% | 188,915 | +675.5% | 0.01% | +700.0% |
| Q1 2020 | $121,000 | -0.8% | 24,361 | -20.7% | 0.00% | – |
| Q1 2019 | $122,000 | -56.3% | 30,737 | -56.2% | 0.00% | -100.0% |
| Q4 2018 | $279,000 | +113.0% | 70,181 | +269.5% | 0.00% | – |
| Q3 2018 | $131,000 | – | 18,995 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $32,263 | 100.00% |
| Opaleye Management Inc. | 6,105,900 | $32,178,093 | 9.64% |
| DELTEC ASSET MANAGEMENT LLC | 1,913,612 | $10,084,735 | 2.49% |
| Knoll Capital Management, LLC | 200,000 | $1,504,000 | 2.32% |
| Endurant Capital Management LP | 512,744 | $2,702,161 | 1.39% |
| Knoll Capital Management, LLC | 95,800 | $504,866 | 0.78% |
| Covestor Ltd | 60,008 | $316 | 0.28% |
| Ikarian Capital, LLC | 200,000 | $1,054,000 | 0.24% |
| EAM Investors, LLC | 224,211 | $1,181,592 | 0.23% |
| Nebula Research & Development LLC | 22,474 | $118,438 | 0.21% |